GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 768 filers reported holding GLAXOSMITHKLINE PLC in Q4 2017. The put-call ratio across all filers is 1.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $61,590,000 | +23.3% | 1,517 | +31.0% | 0.01% | +25.0% |
| Q2 2017 | $49,933,000 | -36.0% | 1,158 | -37.4% | 0.00% | -42.9% |
| Q1 2017 | $78,038,000 | +189.1% | 1,851 | +164.1% | 0.01% | +133.3% |
| Q4 2016 | $26,996,000 | -78.1% | 701 | -75.3% | 0.00% | -81.2% |
| Q2 2016 | $123,086,000 | +1255.1% | 2,840 | +1167.9% | 0.02% | +1500.0% |
| Q1 2016 | $9,083,000 | -22.1% | 224 | -22.5% | 0.00% | -50.0% |
| Q4 2015 | $11,661,000 | -86.1% | 289 | -84.1% | 0.00% | -88.9% |
| Q3 2015 | $83,804,000 | +90.9% | 1,823 | +122.0% | 0.02% | +80.0% |
| Q2 2015 | $43,907,000 | +380.5% | 821 | +314.6% | 0.01% | +400.0% |
| Q1 2015 | $9,138,000 | -13.8% | 198 | -20.2% | 0.00% | -33.3% |
| Q4 2014 | $10,600,000 | -87.4% | 248 | -86.4% | 0.00% | -82.4% |
| Q3 2014 | $83,803,000 | +356.8% | 1,823 | +431.5% | 0.02% | +142.9% |
| Q2 2014 | $18,344,000 | +0.1% | 343 | 0.0% | 0.01% | -36.4% |
| Q1 2014 | $18,326,000 | – | 343 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |